Cosan S.A. Sponsored ADR CSAN 深 滬
已收盤 02-06 16:00:00 美东时间
4.42
+0.160
+3.76%
華盛通- 最 高4.43
- 今 開4.32
- 成交量 112.98万股
- 最 低 4.27
- 昨 收 4.26
- 總市值 43.75亿
- 52周最高 6.2499
- 市盈率 靜 --
- 換手率 0.11%
- 52周最低 3.715
- 委 比 95.45%
- 總股本 9.90亿
- 歷史最高 20.0408
- 量 比 0.80
- 振 幅 3.76%
- 歷史最低 3.715
- 每 手 1
- 風險率 0.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cosan SA Shareholders Unbundle Stakes in Vertiz and Hold Direct Company Shares
Cosan SA Shareholders Unbundle Stakes in Vertiz and Hold Direct Company Shares Cosan S.A. announced that, pursuant to its shareholders' agreement, certain shareholders—specifically the BTG Vehicles and the Perfin Vehicle—have unbundled a portion of their shareholding in Vertiz Holding S.A. and now h
02-02 19:07
Cosan S.A. Enhances Liquidity with Strategic Rumo Share Sale
An update from Cosan ( ($CSAN) ) is now available. On December 15, 2025, Cosan ...
2025-12-16 19:47
美股大行评级 | 高盛上调梅西百货目标价至22美元！ 摩根大通上调美国铝业公司目标价至45美元
今日重点评级关注：Stifel：维持X4 Pharmaceuticals"买入"评级，目标价从7.5美元升至10美元；花旗：维持UP Fintech Holding"买入"评级，目标价从17.4美元升至17.5美元
2025-12-08 08:34
HSBC upgrades Cosan S.A. (CSAN3) to a Hold
HSBC analyst Lilyanna Yang upgraded Cosan S.A. to a Hold yesterday and set a pr...
2025-12-05 18:15
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
2025-12-02 09:50
Goldman Sachs Maintains Neutral on Cosan, Lowers Price Target to $4.5
Goldman Sachs analyst Bruno Amorim maintains Cosan (NYSE:CSAN) with a Neutral and lowers the price target from $5 to $4.5.
2025-12-02 02:15
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
2025-09-23 09:52
HSBC Downgrades Cosan to Reduce, Announces $4.4 Price Target
HSBC analyst Lilyanna Yang downgrades Cosan (NYSE:CSAN) from Hold to Reduce and announces $4.4 price target.
2025-09-22 21:24
Cosan Confirms Ongoing Talks With Potential Investors For Raízen Joint Venture With Shell; No Binding Commitments Yet
COSAN S.A. ((B3: CSAN3, NYSE:CSAN) ("Cosan" or "Company), in compliance with the provisions of CVM Resolution No. 44, dated August 23, 2021, informs its shareholders and the market in general that, considering news
2025-09-04 23:54
美股大行评级 | 最高至425美元！MONGODB获多家机构上调目标价；德银上调回声星通信(SATS)目标价升至67美元
今日重点评级关注：Oppenheimer：维持Chemomab Therapeutics"跑赢大市"评级，目标价从10美元升至25美元；花旗：维持MongoDB"买入"评级，目标价从405美元升至425美元
2025-08-28 09:51
